The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
NCT ID: NCT04799600
Last Updated: 2021-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
158 participants
OBSERVATIONAL
2020-09-01
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
NCT07089693
Acute Kidney Injury in Patients With CoVID-19
NCT04872764
Patients With Acute Renal Failure During Severe COVID-19
NCT05077163
COVID-19 RELATED KIDNEY DAMAGE
NCT04706325
Acute Kidney Injury Risk in COVID-19
NCT04874779
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute Renal Failure in ICU
COVID-19 Patients with Acute Renal Failure in ICU
BRESCİA-COVİD Respiratory Severity Scale
KDIGO acute renal failure score BRESCİA-COVID Respiratory Severity Score
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BRESCİA-COVİD Respiratory Severity Scale
KDIGO acute renal failure score BRESCİA-COVID Respiratory Severity Score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ismail aytaç
medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
betül aytaç, MD
Role: PRINCIPAL_INVESTIGATOR
ankara ch bilkent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454.
Wang L, Li X, Chen H, Yan S, Li D, Li Y, Gong Z. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020;51(5):343-348. doi: 10.1159/000507471. Epub 2020 Mar 31.
Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, Friedman HJ, Hines DW. Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int J Infect Dis. 2021 Jan;102:571-576. doi: 10.1016/j.ijid.2020.11.003. Epub 2020 Nov 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E1-20-1443
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.